Sharma P, Arvidsson A K, Wraith A, Beck-Sickinger A G, Jönsson-Rylander A C, Larhammar D
Unit of Pharmacology, Uppsala University, Uppsala, SE-75124, Sweden.
Gen Comp Endocrinol. 1999 Sep;115(3):422-8. doi: 10.1006/gcen.1999.7332.
Five members of the neuropeptide Y (NPY) receptor family have been cloned in mammals. The recently cloned NPY receptor in the Atlantic cod seems to be distinct from the mammalian subtypes as it has only 50% identity to Y1, Y4, and y6 and only 30% to Y2 and Y5. In most of the other families of G-protein-coupled receptors, species homologues have 65-90% identity between fishes and mammals. The functional expression and detailed pharmacological characterization of this cod NPY receptor, designated Yb, is reported. Membranes of cells transiently transfected with cod Yb showed saturable [(125)I]PYY binding with a K(d) of 45 pM. The pharmacological profile is similar to those of both the zebrafish Yb and Yc receptors and distinct from those of the mammalian NPY receptors. In competition experiments the cod Yb receptor had the following rank order of potencies: porcine PYY = porcine NPY = p[Leu(31), Pro(34)]NPY > zebrafish PYY > zebrafish NPY >> NPY2-36 = NPY3-36 > NPY18-36 > bovine PP = [D-Trp(32)]NPY > BIBP3226. This is in sharp contrast to the high selectivity of BIBP3226 for the Y1 receptor from all mammalian species. Together with the low amino acid identity of cod Yb with the mammalian Y1, Y4, and y6 receptors, this is further support for the notion that fish Yb constitutes a distinct NPY receptor subtype.
在哺乳动物中已克隆出神经肽Y(NPY)受体家族的五个成员。最近在大西洋鳕鱼中克隆出的NPY受体似乎与哺乳动物的亚型不同,因为它与Y1、Y4和Y6的同一性仅为50%,与Y2和Y5的同一性仅为30%。在大多数其他G蛋白偶联受体家族中,鱼类和哺乳动物的物种同源物之间的同一性为65%-90%。本文报道了这种命名为Yb的鳕鱼NPY受体的功能表达和详细的药理学特征。用鳕鱼Yb瞬时转染的细胞的膜显示出可饱和的[(125)I]PYY结合,解离常数(K(d))为45 pM。其药理学特征与斑马鱼的Yb和Yc受体相似,与哺乳动物的NPY受体不同。在竞争实验中,鳕鱼Yb受体具有以下效价顺序:猪PYY = 猪NPY = p[Leu(31), Pro(34)]NPY > 斑马鱼PYY > 斑马鱼NPY >> NPY2-36 = NPY3-36 > NPY18-36 > 牛胰多肽 = [D-Trp(32)]NPY > BIBP3226。这与BIBP3226对所有哺乳动物物种的Y1受体的高选择性形成鲜明对比。再加上鳕鱼Yb与哺乳动物Y1、Y4和Y6受体的低氨基酸同一性,这进一步支持了鱼类Yb构成一种独特的NPY受体亚型的观点。